Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 22, 2026

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

14.1K

Tissue engineering.

Ravi S Katari, Andrea Peloso, Giuseppe Orlando

    Advances in Surgery
    |October 9, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Tissue engineering (TE) offers significant advancements for general surgery, potentially reducing the need for immunosuppression and overcoming challenges like donor site morbidity and immune rejection. Further research in biomaterials and stem cells will enhance regenerative therapies for patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adenosine as a modulator of human islet function and hypoxic tolerance.

    Frontiers in bioengineering and biotechnology·2026
    Same author

    Outcomes Following Alemtuzumab Induction in Deceased Donor Kidney Transplantation According to Recipient Age Categories: A Single Center Report.

    Clinical transplantation·2026
    Same author

    Assessing Knowledge About Living Kidney Donation Among Transplant Candidates and Relationship to Seeking a Living Donor.

    Clinical transplantation·2026
    Same author

    The Use of Pediatric Donors in Pancreas Transplantation.

    Clinical transplantation·2026
    Same author

    Revealing institutional vulnerabilities in Nordic health systems through multidimensional scaling of COVID-19 mortality data.

    Scientific reports·2026
    Same author

    Therapeutic and mechanistic insights on mitochondrial transplantation in kidney disease.

    Nature reviews. Nephrology·2026
    Same journal

    Total Pancreatectomy and Islet Cell Autotransplantation: Does It Have Long Lasting Benefits?

    Advances in surgery·2025
    Same journal

    Clinical Decision-Making for Patients with Chronic Limb-Threatening Ischemia.

    Advances in surgery·2025
    Same journal

    What Is the Role of Irreversible Electroporation for Pancreatic Cancer?

    Advances in surgery·2025
    Same journal

    Airway Foreign Bodies in Children: Old Problem, New Advances.

    Advances in surgery·2025
    Same journal

    Digestive Foreign Bodies in Children: Old Problems, New Complexities.

    Advances in surgery·2025
    Same journal

    Management of Abdominal Wall Mesh Infections.

    Advances in surgery·2025
    See all related articles

    Area of Science:

    • Regenerative Medicine
    • Biomaterials Science
    • Stem Cell Biology
    • Surgical Innovation

    Background:

    • Current surgical practices in reconstruction and transplantation face challenges including donor site morbidity and the lifelong need for immunosuppression.
    • Significant progress in tissue engineering (TE) presents opportunities to address these limitations.
    • Biomaterials and stem cell research are crucial companion fields requiring further development.

    Purpose of the Study:

    • To highlight the monumental progress in tissue engineering (TE) and its implications for general surgery.
    • To emphasize the potential of regenerative approaches in overcoming current surgical obstacles.
    • To underscore the importance of integrating TE research with surgical disciplines like reconstruction and transplantation.

    More Related Videos

    Experimental Approaches to Tissue Engineering
    16:41

    Experimental Approaches to Tissue Engineering

    Published on: August 30, 2007

    6.3K
    Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
    05:52

    Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

    Published on: September 27, 2019

    9.8K

    Related Experiment Videos

    Last Updated: Apr 22, 2026

    Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
    09:24

    Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

    Published on: October 3, 2014

    14.1K
    Experimental Approaches to Tissue Engineering
    16:41

    Experimental Approaches to Tissue Engineering

    Published on: August 30, 2007

    6.3K
    Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
    05:52

    Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

    Published on: September 27, 2019

    9.8K

    Main Methods:

    • Review and summarization of recent studies in tissue engineering.
    • Exploration of the engineering and ex vivo proliferation of autologous cells, tissues, and organs.
    • Analysis of the impact of TE on reducing donor site morbidity and immunologic rejection.

    Main Results:

    • Demonstrated monumental progress in tissue engineering (TE) across various studies.
    • Identified the potential of TE to enable freedom from immunosuppression, a major goal in modern surgery.
    • Showcased the capacity of engineered autologous tissues and organs to mitigate surgical complications.

    Conclusions:

    • Regenerative approaches in general surgery warrant deeper exploration.
    • Tissue engineering (TE) holds the potential to revolutionize reconstruction and transplantation by eliminating the need for immunosuppression.
    • Clinically adapted TE therapies offer substantial benefits for patients with end-stage diseases and debilitating injuries, alongside commercial prospects.